Nasal spray for depression with suicidal thoughts
Part of Mental health clinical trials.
This trial tests an experimental nasal spray for people with major depression who are currently having suicidal thoughts. It aims to see if the spray can quickly reduce depression and suicidal feelings.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have major depression (without hallucinations or delusions) and feel suicidal right now.
- You do not have bipolar disorder, obsessive-compulsive disorder, or a history of psychosis.
- You do not have severe alcohol or drug problems in the last 6 months.
- You have not had treatment-resistant depression before.
- You are not pregnant, breastfeeding, or planning to become pregnant.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if inhaling DMT can help treat moderate to severe major depression. You may qualify if your depression has lasted at least two weeks and you have not changed medications recently.
This trial tests an investigational medication for adults with major depressive disorder who are currently taking an antidepressant but still have symptoms. It aims to see if adding this new drug can improve mood better than a placebo.
This research study tests different medication approaches for people with major depression who are having thoughts of suicide. The goal is to understand which treatments work best and why, so doctors can help patients more effectively.
This study tests if ketamine can help reduce suicidal thoughts in people with major depression. You'll receive ketamine treatment and be monitored closely.
This study tests how ketamine affects brain chemicals linked to suicidal thoughts in people with depression. You will receive ketamine and have brain scans (PET and MRI) to see if it changes activity in opioid receptors.
This study tests whether a nasal spray containing two medications (esketamine and dexmedetomidine) can help prevent postpartum depression in pregnant women who show early signs of depression. Postpartum depression is common and can be serious, so this trial explores a new way to treat it right around the time of delivery.
Hear when a new Major Depressive Disorder (MDD trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.